Structure-activity Studies in a Family of Beta-hairpin Protein Epitope Mimetic Inhibitors of the P53-HDM2 Protein-protein Interaction
Overview
Authors
Affiliations
Inhibitors of the interaction between the p53 tumor-suppressor protein and its natural human inhibitor HDM2 are attractive as potential anticancer agents. In earlier work we explored designing beta-hairpin peptidomimetics of the alpha-helical epitope on p53 that would bind tightly to the p53-binding site on HDM2. The beta-hairpin is used as a scaffold to display energetically hot residues in an optimal array for interaction with HDM2. The initial lead beta-hairpin mimetic, with a weak inhibitory activity (IC(50)=125 microM), was optimized to afford cyclo-(L-Pro-Phe-Glu-6ClTrp-Leu-Asp-Trp-Glu-Phe-D-Pro) (where 6ClTrp=L-6-chlorotryptophan), which has an affinity almost 1,000 times higher (IC(50)=140 nM). In this work, insights into the origins of this affinity maturation based on structure-activity studies and an X-ray crystal structure of the inhibitor/HDM2(residues 17-125) complex at 1.4 A resolution are described. The crystal structure confirms the beta-hairpin conformation of the bound ligand, and also reveals that a significant component of the affinity increase arises through new aromatic/aromatic stacking interactions between side chains around the hairpin and groups on the surface of HDM2.
Cheng J, Zhou J, Kong L, Wang H, Zhang Y, Wang X RSC Med Chem. 2023; 14(12):2496-2508.
PMID: 38107173 PMC: 10718590. DOI: 10.1039/d3md00487b.
Thomas E, Thankan R, Purushottamachar P, Weber D, Njar V Cancers (Basel). 2023; 15(4).
PMID: 36831540 PMC: 9954018. DOI: 10.3390/cancers15041198.
Protocol for iterative optimization of modified peptides bound to protein targets.
Ochoa R, Cossio P, Fox T J Comput Aided Mol Des. 2022; 36(11):825-835.
PMID: 36258137 PMC: 9640467. DOI: 10.1007/s10822-022-00482-1.
Traceless solid-phase synthesis and β-turn propensity of 1,3-thiazole-based peptidomimetics.
Abdildinova A, Gong Y RSC Adv. 2022; 11(2):1050-1056.
PMID: 35423674 PMC: 8693395. DOI: 10.1039/d0ra10127c.
Li X, Gohain N, Chen S, Li Y, Zhao X, Li B Acta Pharm Sin B. 2021; 11(9):2655-2669.
PMID: 34589387 PMC: 8463443. DOI: 10.1016/j.apsb.2021.06.010.